Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-23

Clinical Trial Update: High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating high-dose buprenorphine induction in the emergency department for opioid use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Opioid Use Disorder | Phase 3 | Status: RECRUITING